Brandtree

Who owns Breathe Right?

Breathe Right is owned by Prestige Consumer Healthcare (the United States, NYSE: PBH), which acquired the brand on 15 June 2026 for $1.04 billion from Foundation Consumer Healthcare.[1][2]

Evidence: Prestige Consumer Healthcare Inc. Form 8-K Exhibit 99.1 - completion of the Breathe Right acquisition, SEC EDGAR, 15 June 2026. Verified from filings; last checked .

Key facts

Current owner
Prestige Consumer Healthcare Inc. verified
Owned since
· deal details
Acquisition price
$1.04 billion
Owner HQ
🇺🇸 United States, Tarrytown, New York
Origin
🇺🇸 United States
Category
Consumer health › Over-the-counter medicine › Cold
Parent ticker
NYSE: PBH
Last verified
· 2 sources

About Breathe Right

Breathe Right nasal strips were created in the 1990s, and Prestige Consumer Healthcare describes the brand as the number one name in the nasal strip category and synonymous with it. Prestige bought it with certain other brands from Foundation Consumer Healthcare for $1.045 billion, about $900 million after expected tax benefits, closing on 15 June 2026, in keeping with its habit of buying established over-the-counter names.

What Prestige Consumer Healthcare's annual report says about Breathe Right

Sentences about Breathe Right from Prestige Consumer Healthcare's latest annual filing[1], copied word for word.

How often Prestige Consumer Healthcare names Breathe Right in its annual report

A plain count of the times the name appears in the text of each annual report, not counting the start of a sentence. A brand that an owner writes about more is usually one it treats as central. The brand is named more often than it was three years earlier.

Annual report filedTimes Breathe Right is named
20263
20250
20240

Ownership timeline of Breathe Right

Owners of Breathe Right over 2026 to 2026 Prestige Consumer Healthcare 2026–present Prestige Consumer Healthcare 20262027
  1. 2026 – present Prestige Consumer Healthcare — acquired 15 June 2026 [1][2] verified

Where Breathe Right sits in Prestige Consumer Healthcare

Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.

Where Breathe Right sits in Prestige Consumer Healthcare Tree of 6 brands under Prestige Consumer Healthcare. Prestige Consumer Healthcare Breathe Right Chloraseptic Clear Eyes Dramamine Nix Summer's Eve

Open the full Prestige Consumer Healthcare ownership tree →

See the full Prestige Consumer Healthcare brand portfolio (6) →

Other brands owned by Prestige Consumer Healthcare

Prestige Consumer Healthcare controls 6 brands on Brandtree, 5 of them in consumer health.

Also in consumer health

All Prestige Consumer Healthcare brands →

Other brands in cold, and who owns them

The 36 brands in cold on Brandtree belong to 21 owners. The largest is Krka, with 5; Prestige Consumer Healthcare has 3.

BrandOwnerOwner based in
Herbion Krka 🇸🇮 Slovenia
Lemsip Reckitt 🇬🇧 United Kingdom
Covonia STADA 🇩🇪 Germany
Dimestil Birzeit Pharmaceutical 🇵🇸 Palestine
HealthCareAisle Dr. Reddy's 🇮🇳 India
Tukol Genomma Lab 🇲🇽 Mexico
Benadryl Kenvue 🇺🇸 United States
Allergosan Sopharma 🇧🇬 Bulgaria

Every brand in cold and its owner →

About the owner: Prestige Consumer Healthcare

Prestige Consumer Healthcare is a publicly listed company headquartered in Tarrytown, New York, United States, founded in 1996. Brandtree records 6 brands under its control, and it is listed as NYSE: PBH.

Prestige Consumer Healthcare buys established over-the-counter medicine brands that larger pharmaceutical companies no longer want to promote, and runs them with low overheads and targeted advertising. Almost its entire portfolio was acquired rather than developed.

Prestige Consumer Healthcare: full profile, brands and acquisition history →

🇺🇸 Breathe Right and other American brands

Brandtree records a controlling owner for 2,570 brands that began in the United States. 501 of them (19%) are now controlled by a company headquartered in another country; Breathe Right is not one of them.

All American brands and who owns them →

Deals involving Breathe Right

Acquisition closed

Prestige Consumer Healthcare acquires Breathe Right

Prestige Consumer Healthcare bought the Breathe Right nasal strip brand and certain other brands from Foundation Consumer Healthcare for $1.045 billion, about $900 million after $150 million of expected tax benefits, and closed on 15 June 2026. When the deal was announced Prestige also named Dimetapp and Anbesol among the brands included. It is a characteristic Prestige purchase: an established over-the-counter name bought from a private owner rather than a brand built from scratch.

Value
$1.04bn
Regulatory
None recorded

Frequently asked questions

Who is the parent company of Breathe Right?

The parent company of Breathe Right is Prestige Consumer Healthcare, a publicly listed company headquartered in the United States.

Is Breathe Right American?

Yes. Breathe Right originated in the United States and its owner, Prestige Consumer Healthcare, is also headquartered in the United States.

When did Prestige Consumer Healthcare buy Breathe Right?

Prestige Consumer Healthcare completed its acquisition of Breathe Right on 15 June 2026, after announcing the deal on 20 March 2026. The deal was valued at $1.04 billion.

Is Breathe Right still owned by Prestige Consumer Healthcare?

Yes. As of 29 October 2026, Breathe Right is still owned by Prestige Consumer Healthcare. The ownership record was last checked against primary sources on that date.

Sources (2) & corrections

Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.

  1. [1] Prestige Consumer Healthcare Inc. Annual Report on Form 10-K filed 2026-05-14 — SEC EDGAR, SEC Form 10-K, published 14 May 2026; retrieved 16 September 2026.
  2. [2] Prestige Consumer Healthcare Inc. Form 8-K Exhibit 99.1 - completion of the Breathe Right acquisition — SEC EDGAR, SEC Form 8-K, published 15 June 2026; retrieved 16 September 2026.

Report a correction Opens a pre-filled GitHub issue. See our corrections policy.